Statistics
Publications
2
Citations
48
H-Index
2
Active since
2020
Affiliations
Rajiv Shinde is an author at Institute of Cancer Research specializing in oncology, dose scheduling, and protein kinase inhibitors.
Publications per year
2020–2025
2
2
Defactinib with avutometinib in patients with solid tumors: the phase 1 FRAME trial
Susana Banerjee, Matthew Krebs, Alastair Greystoke et al. · Nature Medicine · 2025 · 27 citations · Full text
Medicine, Oncology, Pharmacology +17
Rajiv Shinde, Angelika Terbuch, Martin Little et al. · Cancer Research · 2020 · 21 citations
Medicine, Oncology, Pharmacology +14
1–2 of 2